National Health Investors (NYSE:NHI) - Aandelenkoers, Nieuws & Analyse

NHI Overzicht aandelen

National Health Investors, Inc. werd opgericht in 1991.

NHI fundamentele analyse
Sneeuwvlok Score
Waardering	5/6
Toekomstige groei	2/6
Prestaties in het verleden	3/6
Financiële gezondheid	2/6
Dividenden	5/6

Beloningen

Verhandeld tegen 44.3% onder onze schatting van de reële waarde

De winst zal naar verwachting met 9.89% per jaar groeien

Handelen tegen een goede waarde vergeleken met branchegenoten en branchegenoten

Risicoanalyse

De schulden worden niet goed gedekt door de operationele kasstroom

Onstabiel dividend track record

Aandeelhouders zijn het afgelopen jaar verwaterd

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WarrenAI

Based on Analyst Price Targets

Senior Housing Growth And Decisive Investments Set To Boost Investor Confidence

Key Takeaways The company's consistent financial performance and strategic investments indicate a strong potential for revenue and FFO growth. Effective strategy execution, including capital expenditure programs and investment in revenue-generating initiatives, is set to significantly improve net income and margins.

View narrative

US$85.86

10.6% undervalued

17.35%

Revenue growth p.a.

6 days ago

National Health Investors, Inc. Concurrenten

Sabra Health Care REIT

NasdaqGS:SBRA

US$4.4b

CareTrust REIT

NYSE:CTRE

US$5.8b

LTC Properties

NYSE:LTC

US$1.7b

Sila Realty Trust

NYSE:SILA

US$1.4b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor National Health Investors
Historische aandelenkoersen
Huidige aandelenkoers	US$76.73
52 Week Hoogtepunt	US$86.13
52 Week Laag	US$49.25
Bèta	1.06
11 maand verandering	-5.67%
3 maanden verandering	2.79%
1 Jaar Verandering	52.33%
33 jaar verandering	36.46%
5 jaar verandering	-3.25%
Verandering sinds IPO	276.59%

Recent nieuws en updates

National Health Investors: From Struggles To Strength

Sep 29

Recent updates

National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M

Feb 21

6%-Yielding National Health Investors: No Pain, No Gain

Feb 06

National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot

Sep 10

National Health Investors Q2 Earnings Preview

Aug 07

National Health Investors: A 5.8% Yield, And Little Else

Jun 29

Rendement voor aandeelhouders

	NHI	US Health Care REITs	US Markt
7D	-1.0%	0.5%	-1.9%
1Y	52.3%	36.7%	30.4%

Rendement versus industrie: NHI overtrof de US Health Care REITs industrie, die het afgelopen jaar een rendement 36.7 % opleverde.

Rendement versus markt: NHI overtrof de US markt, die het afgelopen jaar een rendement opleverde van 30.4 %.

Prijsvolatiliteit

Is NHI's price volatile compared to industry and market?
NHI volatility
NHI Average Weekly Movement	3.0%
Health Care REITs Industry Average Movement	3.1%
Market Average Movement	6.0%
10% most volatile stocks in US Market	15.0%
10% least volatile stocks in US Market	2.9%

Stabiele aandelenkoers: NHI heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van NHI is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1991	27	D. Mendelsohn	www.nhireit.com

National Health Investors, Inc. (NYSE:NHI), opgericht in 1991, is een vastgoedbeleggingsmaatschappij gespecialiseerd in de verkoop, leasebacks, joint ventures, operationele partnerships voor seniorenwoningen en hypotheek- en mezzaninefinanciering van behoeftegestuurde en discretionaire investeringen in seniorenwoningen en medische voorzieningen. De portefeuille van NHI bestaat uit gemeenschappen voor zelfstandig wonen, begeleid wonen en geheugenzorg, pensiongemeenschappen met entreegelden, geschoolde verpleegfaciliteiten en gespecialiseerde ziekenhuizen.

National Health Investors, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van National Health Investors zich tot de beurswaarde?
NHI fundamentele statistieken
Marktkapitalisatie	US$3.51b
Inkomsten(TTM)	US$127.52m
Inkomsten(TTM)	US$327.01m

27.8x

Koers/Winstverhouding

10.8x

P/S-verhouding

Is NHI overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
NHI resultatenrekening (TTM)
Inkomsten	US$327.01m
Kosten van inkomsten	US$12.37m
Brutowinst	US$314.64m
Overige uitgaven	US$187.13m
Inkomsten	US$127.52m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

Nov 06, 2024

Winst per aandeel (EPS)	2.76
Brutomarge	96.22%
Nettowinstmarge	38.99%
Schuld/Eigen Vermogen Verhouding	89.9%

Hoe presteerde NHI op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

4.7%

Huidig dividendrendement

81%

Uitbetalingsratio

NHI Overzicht aandelen

Beloningen

Risicoanalyse

Senior Housing Growth And Decisive Investments Set To Boost Investor Confidence

National Health Investors, Inc. Concurrenten

NasdaqGS:SBRA

US$4.4b

NYSE:CTRE

US$5.8b

NYSE:LTC

US$1.7b

NYSE:SILA

US$1.4b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

National Health Investors, Inc. to Report Q3, 2024 Results on Nov 05, 2024

National Health Investors: From Struggles To Strength

Senior VP & Chief Transaction Officer exercised options and sold US$752k worth of stock

Upcoming dividend of US$0.90 per share

Executive VP of Finance exercised options and sold US$1.3m worth of stock

Recent updates

National Health Investors, Inc. to Report Q3, 2024 Results on Nov 05, 2024

National Health Investors: From Struggles To Strength

Senior VP & Chief Transaction Officer exercised options and sold US$752k worth of stock

Upcoming dividend of US$0.90 per share

Executive VP of Finance exercised options and sold US$1.3m worth of stock

Executive VP & Chief Investment Officer exercised options and sold US$1.9m worth of stock

Price target increased by 12% to US$78.50

Independent Director exercised options to buy US$767k worth of stock.

New minor risk - Shareholder dilution

National Health Investors, Inc. has completed a Follow-on Equity Offering in the amount of $171 million.

National Health Investors, Inc. has filed a Follow-on Equity Offering.

Second quarter dividend of US$0.90 announced

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Provides Earnings Guidance for the Full Year 2024

Independent Director exercised options and sold US$656k worth of stock

National Health Investors, Inc. to Report Q2, 2024 Results on Aug 06, 2024

National Health Investors, Inc.(NYSE:NHI) dropped from Russell Small Cap Comp Growth Index

Land & Buildings Investment Management Comments on National Health Investors’ Supplemental Proxy Statement

First quarter dividend of US$0.90 announced

National Health Investors: The Lack Of Upside Seems Obvious To Me Here

National Health Investors, Inc. Announces Dividend for the Second Quarter of 2024, Payable on August 2, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting

National Health Investors, Inc. to Report Q1, 2024 Results on May 06, 2024

National Health Investors, Inc., Annual General Meeting, May 22, 2024

Upcoming dividend of US$0.90 per share

Price target increased by 7.2% to US$62.00

Insufficient new directors

Independent Director recently bought US$587k worth of stock

Price target increased by 7.5% to US$59.86

Fourth quarter dividend of US$0.90 announced

National Health: Lots To Love, But Valuation Still On The High Side

Full year 2023 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Provides Earnings Guidance for the Year 2024

National Health Investors, Inc. to Report Q4, 2023 Results on Feb 20, 2024

Upcoming dividend of US$0.90 per share at 6.3% yield

Catch The Senior Housing Rebound With National Health Investors

National Health Investors: 7% Yielding REIT Has Improved On Most Metrics

National Health Investors, Inc. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

National Health Investors, Inc. Announces Its Fourth Quarter Dividend, Payable on January 26, 2024

National Health Investors, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Upcoming dividend of US$0.90 per share at 7.1% yield

National Health Investors: Enjoy This Solid 7%+ Yield, For Now

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

National Health Investors, Inc. Announces Third Quarter 2023 Dividend, Payable on November 3, 2023

National Health Investors, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Upcoming dividend of US$0.90 per share at 6.8% yield

National Health: What We Got Wrong With This Healthcare REIT

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Announces Second Quarter 2023 Dividend, Payable on August 4, 2023

Full year 2022 earnings: EPS misses analyst expectations

National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M

6%-Yielding National Health Investors: No Pain, No Gain

National Health Investors, Inc. to Report Q4, 2022 Results on Feb 21, 2023

Upcoming dividend of US$0.90 per share

Independent Director recently bought US$57k worth of stock

National Health Investors, Inc. (NYSE:NHI) acquired Bickford of Virginia Beach from Bickford Senior Living, L.L.C. for $14 million.